394 related articles for article (PubMed ID: 22569706)
1. Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors.
Mafuvadze B; Liang Y; Besch-Williford C; Zhang X; Hyder SM
Horm Cancer; 2012 Aug; 3(4):160-71. PubMed ID: 22569706
[TBL] [Abstract][Full Text] [Related]
2. Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.
Liang Y; Besch-Williford C; Brekken RA; Hyder SM
Cancer Res; 2007 Oct; 67(20):9929-36. PubMed ID: 17942925
[TBL] [Abstract][Full Text] [Related]
3. Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats.
Mafuvadze B; Benakanakere I; López Pérez FR; Besch-Williford C; Ellersieck MR; Hyder SM
Cancer Prev Res (Phila); 2011 Aug; 4(8):1316-24. PubMed ID: 21505181
[TBL] [Abstract][Full Text] [Related]
4. Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice.
Liang Y; Benakanakere I; Besch-Williford C; Hyder RS; Ellersieck MR; Hyder SM
Menopause; 2010; 17(5):1040-7. PubMed ID: 20461021
[TBL] [Abstract][Full Text] [Related]
5. Molecular modulation of estrogen-induced apoptosis by synthetic progestins in hormone replacement therapy: an insight into the women's health initiative study.
Sweeney EE; Fan P; Jordan VC
Cancer Res; 2014 Dec; 74(23):7060-8. PubMed ID: 25304262
[TBL] [Abstract][Full Text] [Related]
6. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
7. Effects of dietary apigenin on tumor latency, incidence and multiplicity in a medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced breast cancer model.
Mafuvadze B; Cook M; Xu Z; Besch-Williford CL; Hyder SM
Nutr Cancer; 2013; 65(8):1184-91. PubMed ID: 24127693
[TBL] [Abstract][Full Text] [Related]
8. Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts.
Cook MT; Liang Y; Besch-Williford C; Goyette S; Mafuvadze B; Hyder SM
Springerplus; 2015; 4():444. PubMed ID: 26312209
[TBL] [Abstract][Full Text] [Related]
9. Apigenin blocks induction of vascular endothelial growth factor mRNA and protein in progestin-treated human breast cancer cells.
Mafuvadze B; Benakanakere I; Hyder SM
Menopause; 2010; 17(5):1055-63. PubMed ID: 20551847
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
Giulianelli S; Vaqué JP; Soldati R; Wargon V; Vanzulli SI; Martins R; Zeitlin E; Molinolo AA; Helguero LA; Lamb CA; Gutkind JS; Lanari C
Cancer Res; 2012 May; 72(9):2416-27. PubMed ID: 22396492
[TBL] [Abstract][Full Text] [Related]
11. Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells.
Carroll CE; Ellersieck MR; Hyder SM
Menopause; 2008; 15(3):570-4. PubMed ID: 18467956
[TBL] [Abstract][Full Text] [Related]
12. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
Wu J; Brandt S; Hyder SM
Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
[TBL] [Abstract][Full Text] [Related]
13. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS
J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434
[TBL] [Abstract][Full Text] [Related]
14. Progestin effects on cell proliferation pathways in the postmenopausal mammary gland.
Wood CE; Branstetter D; Jacob AP; Cline JM; Register TC; Rohrbach K; Huang LY; Borgerink H; Dougall WC
Breast Cancer Res; 2013; 15(4):R62. PubMed ID: 23938070
[TBL] [Abstract][Full Text] [Related]
15. Re-activation of the p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cells.
Liang Y; Besch-Williford C; Benakanakere I; Hyder SM
Int J Oncol; 2007 Oct; 31(4):777-84. PubMed ID: 17786308
[TBL] [Abstract][Full Text] [Related]
16. Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers.
Guix M; Granja Nde M; Meszoely I; Adkins TB; Wieman BM; Frierson KE; Sanchez V; Sanders ME; Grau AM; Mayer IA; Pestano G; Shyr Y; Muthuswamy S; Calvo B; Krontiras H; Krop IE; Kelley MC; Arteaga CL
J Clin Oncol; 2008 Feb; 26(6):897-906. PubMed ID: 18180460
[TBL] [Abstract][Full Text] [Related]
17. The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development.
Carroll CE; Liang Y; Benakanakere I; Besch-Williford C; Hyder SM
Int J Oncol; 2013 Jan; 42(1):179-87. PubMed ID: 23123638
[TBL] [Abstract][Full Text] [Related]
18. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
19. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts.
Chen D; Landis-Piwowar KR; Chen MS; Dou QP
Breast Cancer Res; 2007; 9(6):R80. PubMed ID: 18300387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
